Nicola Stagg

Nicola Stagg

Company: Genentech

Job title: Senior Scientist & Toxicologist


Dr. Stagg is a DABT Senior Scientist/Toxicologist and Toxicology Oncology Therapeutic Area Lead in Safety Assessment at Genentech. In this role, she manages the oncology portfolio and serves as lead toxicologist for several ADCs, biotherapeutics and small molecules from discovery to clinical development in different therapeutic areas. She manages a group of toxicology analysts that scientifically and operationally support project scientists in safety assessment. She is also a pharmacology subteam lead for an oncology biotherapeutic and a safety rep for CMC-quality related toxicology issues for biotherapeutics.   Prior to joining Genentech, Dr. Stagg worked as a Manager of Toxicology at Agensys, LLC, the oncology division of Astellas Pharma on ADCs and other biotherapeutics and as a Senior Toxicologist at Dow Agrosciences on pesticides and biotechnology derived proteins for genetically engineered crops. Dr. Stagg received her doctorate in the field of Pharmacology and Toxicology from the University of Arizona with a focus on peripheral neuropathy. Dr. Stagg is a diplomate of the American Board of Toxicology (DABT) and has nearly 13 years of experience as a toxicologist in industry (biopharma/pharma and other) conducting GLP/non-GLP nonclinical toxicology assessments for human health safety in support of global regulatory filings. She is author of 18 peer-reviewed journal articles, 2 patents and over 25 external presentations/conference chair positions. 

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.